842149-00-2Relevant academic research and scientific papers
ALLOSTERIC MODULATORS OF THE CANNIBINOID 1 RECEPTOR
-
Paragraph 0235, (2015/03/13)
The present technology relates to compounds and compositions of Formulas I, II, VII, and VIII, and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of addiction, metabolic syndrome, obesity, and/or a CB1 receptor-medited disorder.
INHIBITORS OF Akt ACTIVITY
-
Page/Page column 166-167, (2010/02/10)
Invented are novel 1 H-imidazo[4,5-c]pyridin-2-yI compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
